What is the diagnosis for a 34-year-old patient with progressive premature aging after puberty, including prematurely aged facies, bilateral cataracts, thin scleroderma‑like skin, loss of subcutaneous tissue, marked limb wasting, short stature, distal extremity atrophy, chronic hyperpigmentation, early‑onset metabolic and vascular complications, and a pathogenic biallelic variant in the WRN DNA helicase gene?

Werner Syndrome

This patient has Werner syndrome (WS), an autosomal recessive premature aging disorder caused by biallelic pathogenic variants in the WRN gene encoding a RecQ DNA helicase. The constellation of premature aging after puberty, bilateral cataracts, scleroderma-like skin, subcutaneous tissue loss, limb wasting, short stature, and metabolic/vascular complications with confirmed WRN gene mutations is pathognomonic for this condition 1, 2, 3.

Clinical Diagnosis

The diagnosis is established by:

• Classic phenotypic features: The patient exhibits the cardinal manifestations including:

  • Premature aging beginning after puberty (not from birth)
  • Bilateral juvenile cataracts (highly characteristic)
  • Scleroderma-like skin changes with atrophy 4
  • "Bird-like" facies with characteristic appearance 3
  • Short stature and marked limb wasting
  • Loss of subcutaneous tissue
  • Chronic hyperpigmentation

• Molecular confirmation: Biallelic pathogenic variants in the WRN gene definitively confirm the diagnosis 1, 2. The WRN protein is a RecQ family DNA helicase with unique N-terminal exonuclease activity, critical for DNA repair, replication, recombination, and telomere maintenance 2.

Key Distinguishing Features

Werner syndrome differs from other progeroid syndromes by:

• Post-pubertal onset of aging features (not congenital)
• Bilateral cataracts as a nearly universal finding
• Scleroderma-like skin rather than other dermatologic patterns
• Specific metabolic complications: diabetes mellitus, dyslipidemia, hypogonadism 1
• Early atherosclerosis and vascular disease

Critical Management Priorities for Morbidity and Mortality

The leading causes of death in Werner syndrome are atherosclerosis and cancer 1. Management must aggressively target these:

Cardiovascular Disease Prevention

• Aggressive lipid management for severe dyslipidemia
• Diabetes control (common comorbidity)
• Blood pressure optimization
• Early screening for atherosclerotic disease
• Consider cardiology consultation for risk stratification

Cancer Surveillance

While the provided guidelines focus on other genomic instability disorders 5, Werner syndrome patients have elevated cancer risk, particularly:

• Soft tissue sarcomas
• Thyroid cancer
• Melanoma
• Hematologic malignancies

Annual comprehensive physical examination with attention to skin lesions, thyroid nodules, and lymphadenopathy is essential.

Metabolic Management

• Screen and treat diabetes mellitus aggressively 1
• Manage severe hypertriglyceridemia to prevent pancreatitis
• Monitor for thyroid dysfunction
• Address hypogonadism if present

Wound Care

• Non-healing ulcers (as in this patient) require specialized wound care
• Prevent trauma to atrophic skin
• Early treatment of infections

Common Pitfalls

Do not confuse Werner syndrome with Hutchinson-Gilford progeria syndrome (childhood onset) or systemic sclerosis (different genetic basis, no WRN mutations). The post-pubertal onset and bilateral cataracts are key differentiators 4.

Do not delay genetic testing when clinical features are suggestive—molecular confirmation guides family counseling and may have implications for cancer surveillance strategies 3.

Prognosis

Average life expectancy is approximately 46 years, with death typically from cardiovascular disease or malignancy 4. Early identification and aggressive management of these complications is the primary strategy to improve both quality of life and survival.